Terminology Service for NFDI4Health
E-CMF Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C64366
A regimen consisting of epirubicin, followed by cyclophosphamide, methotrexate, fluorouracil (CMF), used in the adjuvant setting for the treatment of breast cancer. [ ]
Term info
Label
E-CMF Regimen
Synonyms
- E-CMF Regimen
- Epirubicin-Cytoxan-Methotrexate-Fluorouracil Regimen
Subsets
NCIT_C160952, NCIT_C160950
DesignNote
Source: NCCN Guidelines 2007
Legacy Concept Name
E-CMF_Regimen
Preferred Name
E-CMF Regimen
Semantic Type
Therapeutic or Preventive Procedure
UMLS CUI
C1880431
code
C64366
Term relations
Subclass of:
- Regimen Used to Treat Breast Carcinoma
- Chemotherapy_Regimen_Has_Component some Methotrexate
- Chemotherapy_Regimen_Has_Component some Fluorouracil
- Regimen_Has_Accepted_Use_For_Disease some Breast Carcinoma
- Chemotherapy_Regimen_Has_Component some Cyclophosphamide
- Chemotherapy_Regimen_Has_Component some Epirubicin Hydrochloride